Extrapulmonary Small Cell Carcinoma - a Case Series of Oropharyngeal and Esophageal Primary Sites Treated with Chemo-Radiotherapy

  • Sahai, Puja ;
  • Baghmar, Saphalta ;
  • Nath, Devajit ;
  • Arora, Saurabh ;
  • Bhasker, Suman ;
  • Gogia, Ajay ;
  • Sikka, Kapil ;
  • Kumar, Rakesh ;
  • Chander, Subhash
  • Published : 2015.11.04


Background: The optimal sequence and extent of multimodality therapy remains to be defined for extrapulmonary small cell carcinoma because of its rarity. The purpose of our study was to assess the response to neoadjuvant chemotherapy followed by chemoradiation/radiation in patients with extrapulmonary small cell carcinoma. Materials and Methods: Four consecutively diagnosed patients were included in this study. The primary tumor site was oropharynx in three patients and esophagus in one. The patients with the limited disease were treated with chemotherapy followed by concurrent chemoradiation (n=2) or radiotherapy (n=1). The patient with the extensive disease with the primary site in vallecula was treated with chemotherapy and palliative radiotherapy to the metastatic site. Results: The median follow-up was 22.5 months (range, 8-24 months). Three patients with the limited disease (base of tongue, n=2; esophagus, n=1) were in complete remission. The patient with the extensive disease died of loco-regional tumor progression at 8 months from the time of diagnosis. Conclusions: The combination of chemotherapy and radiotherapy is the preferred therapeutic approach for patients with extrapulmonary small cell carcinoma. Induction chemotherapy followed by concurrent chemoradiation or radiation provides a good loco-regional control in patients with limited disease.


small cell carcinoma;neuroendocrine carcinoma;extrapulmonary;head and neck neoplasms;esophagus


  1. Barker JL Jr, Glisson BS, Garden AS, et al (2003). Management of nonsinonasal neuroendocrine carcinomas of the head and neck. Cancer, 98, 2322-8.
  2. Brennan SM, Gregory DL, Stillie A, et al (2010). Should extrapulmonary small cell cancer be managed like small cell lung cancer? Cancer, 116, 888-95.
  3. Fruh M, Kacsir B, Ess S, et al (2011). Extrapulmonary small cell carcinoma: An indication for prophylactic cranial irradiation? A single center experience. Strahlenther Onkol, 187, 561-7.
  4. Gollard R, Ellis C, VanderHarten C (2010). Small cell/ neuroendocrine tumors of the esophagus: presentation of two cases and review of the literature. Tumori, 96, 780-3.
  5. Gregory DL, Brennan SM, Stillie A, et al (2010). Impact of 18F-fluorodeoxyglucose positron emission tomography in the staging and treatment response assessment of extrapulmonary small-cell cancer. J Med Imaging Radiat Oncol, 54, 100-7.
  6. Haider K, Shahid RK, Finch D, et al (2006). Extrapulmonary small cell cancer: a Canadian province’s experience. Cancer, 107, 2262-9.
  7. Han G, Wang Z, Guo X, et al (2012). Extrapulmonary small cell neuroendocrine carcinoma of the paranasal sinuses: a case report and review of the literature. J Oral Maxillofac Surg, 70, 2347-51.
  8. Kim JH, Lee SH, Park J, et al (2004). Extrapulmonary smallcell carcinoma: a single-institution experience. Jpn J Clin Oncol, 34, 250-4.
  9. Lee SS, Lee JL, Ryu MH, et al (2007). Extrapulmonary small cell carcinoma: single center experience with 61 patients. Acta Oncol, 46, 846-51.
  10. Lin IH, Hwang CF, Huang HY, Chien CY (2007). Small cell carcinoma of the nasopharynx. Acta Otolaryngol, 127, 206-8.
  11. Lin YL, Chung CY, Chang CS, et al (2007). Prognostic factors in extrapulmonary small cell carcinomas. A large retrospective study. Oncology, 72, 181-7.
  12. Naidoo J, Teo MY, Deady S, Comber H, Calvert P (2013). Should patients with extrapulmonary small-cell carcinoma receive prophylactic cranial irradiation? J Thorac Oncol, 8, 1215-21.
  13. Nakahara S, Takemoto N, Inohara H (2012). Small cell carcinoma of the larynx treated by concurrent chemoradiotherapy: a case report. Case Rep Otolaryngol, 2012, 316165.
  14. Ochsenreither S, Marnitz-Schultze S, Schneider A, et al (2009). Extrapulmonary small cell carcinoma (EPSCC): 10 years' multi-disciplinary experience at Charite. Anticancer Res, 29, 3411-5.
  15. Segawa Y, Nakashima T, Shiratsuchi H, et al (2011). Small cell carcinoma of the tonsil treated with irinotecan and Cisplatin: a case report and literature review. Case Rep Oncol, 4, 587-91.
  16. van der Laan TP, Plaat BE, van der Laan BF, Halmos GB (2015). Clinical recommendations on the treatment of neuroendocrine carcinoma of the larynx: A meta-analysis of 436 reported cases. Head Neck, 37, 707-15.
  17. Wong YN, Jack RH, Mak V, Henrik M, Davies EA (2009). The epidemiology and survival of extrapulmonary small cell carcinoma in South East England, 1970-2004. BMC Cancer, 9, 209.
  18. Yazici O, Ozdemir NY, Sendur MA, Aksoy S, Zengin N (2014). Current approaches for prophylactic cranial irradiation in extrapulmonary small cell carcinoma. Curr Med Res Opin, 30, 1327-36.

Cited by

  1. Primary neuroendocrine neoplasm of the esophagus – Report of 14 cases from a single institute and review of the literature vol.54, pp.1, 2017,